Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Both medications belong to the incretin family, but have different mechanisms of action, dosing, FDA-approved uses, and side effect profiles
Trial averages: 20.2% on tirzepatide and 13.7% on semaglutide at 72 weeks (SURMOUNT-5)
This is actually part of my own nightly routine too
Promotes weight loss: By delaying gastric emptying (how quickly food leaves your stomach), Semaglutide reduces appetite and increases feelings of fullness
Statistical analysis We characterized the baseline characteristics of the combination and monotherapy groups by reporting frequency distributions (counts and percentages) for categorical variables and descriptive statistics (means and standard deviations [SDs]) for continuous variables
SIS PLC, 16-18 Hatton Garden, Farringdon, London, EC1N 8AT
